As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another ...

Mucinex maker Reckitt Beckiser’s new “simpler and more effective organization” won’t include 190 New Jersey workers. | ...

A New York City federal court has dismissed a proposed class action lawsuit against Bristol Myers Squibb that accused the ...

While the omission of pharmaceuticals from President Donald Trump’s much-anticipated reciprocal tariffs gave the industry a ...

Shipping and logistics giant DHL Group is earmarking 2 billion euros ($2.2 billion) to bulk up its healthcare supply chain ...

Merz Aesthetics has extended its starry marketing strategy, signing up Salma Hayek Pinault as the first global brand ...

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma ...

Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...

Although President Donald Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import taxes ...

Following a second measles-related death in Texas, Robert F. | The HHS secretary called out the measles vaccines as "the most ...

As the countdown to the launch of its first therapeutic continues, Rocket Pharmaceuticals is fueling up its commercial team.

While Gilead is eliminating 149 positions at its headquarters in Foster City, Roche is letting go of 108 workers at its ...